Expression of alternatively spliced Runx2 in multiple myeloma patients and a shift in expression in response to thalidomide treatment.

被引：0
|
作者：
Bose, N
Bergemann, H
Westendorf, JJ
Rajkumar, SV
Masellis, AM
机构：
[1] Virginia Piper Canc Inst, Minneapolis, MN USA
[2] Univ Minnesota, Orthopaed Surg & Canc Ctr, Minneapolis, MN 55455 USA
[3] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [1] Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells
    Makita, Naoyuki
    Suzuki, Mitsuhiro
    Asami, Shiori
    Takahata, Rintaroh
    Kohzaki, Daika
    Kobayashi, Sho
    Hakamazuka, Takashi
    Hozumi, Nobumichi
    GENE, 2008, 413 (1-2) : 8 - 17
  • [2] Osteocalcin, Osteopontin and RUNX2 Expression in Patients' Leucocytes with Arteriosclerosis
    Ukkat, Jorg
    Hoang-Vu, Cuong
    Trojanowicz, Bogusz
    Rebelo, Artur
    DISEASES, 2021, 9 (01)
  • [3] Cranial suture response to stress: Expression patterns of Noggin and Runx2
    Heller, Justin B.
    Gabbay, Joubin S.
    Wasson, Kristy
    Mitchell, Scott
    Heller, Misha M.
    Zuk, Patricia
    Bradley, James P.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2007, 119 (07) : 2037 - 2045
  • [4] DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?
    de la Rubia, Javier
    Such, Esperanza
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 1960 - 1961
  • [5] Impaired in vitro osteogenesis and defective Runx2 activity in multiple myeloma patients.
    Westendorf, JJ
    Evenson, K
    Kahler, RA
    Li, X
    Masellis, AM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S184 - S184
  • [6] Do baseline Cereblon gene expression and IL-6 receptor expression determine the response to thalidomide-dexamethasone treatment in Multiple myeloma patients?
    Bedewy, Ahmed M. L.
    EL-Maghraby, Shereen M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (01) : 13 - 18
  • [7] Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter
    Lee, MH
    Kim, YJ
    Yoon, WJ
    Kim, JI
    Kim, BG
    Hwang, YS
    Wozney, JM
    Chi, XZ
    Bae, SC
    Choi, KY
    Cho, JY
    Choi, JY
    Ryoo, HM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35579 - 35587
  • [8] Multiple myeloma in elderly patients: A study of survival, prognostic factors and response to treatment.
    Rodon, P
    Gauvain, JB
    Linassier, C
    Luthier, F
    Maigre, M
    Goupille, P
    Cusson, P
    Lucas, V
    Dugay, J
    Allais, C
    Colombat, P
    BLOOD, 1997, 90 (10) : 4108 - 4108
  • [9] Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
    Shang-Yi Huang
    Chung-Wu Lin
    Hsiu-Hsia Lin
    Ming Yao
    Jih-Luh Tang
    Shang-Ju Wu
    Yao-Chang Chen
    Hsiao-Yun Lu
    Hsin-An Hou
    Chien-Yuan Chen
    Wen-Chien Chou
    Woei Tsay
    Sheng-Je Chou
    Hwei-Fang Tien
    Annals of Hematology, 2014, 93 : 1371 - 1380
  • [10] Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
    Huang, Shang-Yi
    Lin, Chung-Wu
    Lin, Hsiu-Hsia
    Yao, Ming
    Tang, Jih-Luh
    Wu, Shang-Ju
    Chen, Yao-Chang
    Lu, Hsiao-Yun
    Hou, Hsin-An
    Chen, Chien-Yuan
    Chou, Wen-Chien
    Tsay, Woei
    Chou, Sheng-Je
    Tien, Hwei-Fang
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1371 - 1380
12345